The global Bio-active Peptide market is projected to witness substantial growth, increasing from USD 2,508.3 million in 2023 to USD 4,191.8 million by 2033, with a notable compound annual growth rate (CAGR) of 5.3% during the projection period.
Key Trends Listed by Future Market Insights (FMI):
In fish processing, a large number of by-products, including bones, heads, skin, and viscera get wasted or downgraded as feed on a regular basis.
These by-products are high in proteins and bioactive nitrogenous compounds, which can be transformed into peptides through bacterial fermentation and enzymatic hydrolysis.
Peptides are physiologically active as they assist in physiological functions in organisms along with increasing applications in the pharmaceutical and food industry.
In the food industry, bioactive peptides are used as antioxidants and preservatives to prevent food spoilage.
Peptides have functional properties which are used in various aspects of food processing, such as solubility, fat-binding, water-holding capacity, and gel-forming
Various research shows that bioactive peptides have valuable applications in the pharmaceutical industry as an antioxidant, anticoagulants, antihypertensives, and immunomodulators. These properties make peptides attractive ingredient for the development of functional foods and nutraceuticals with desirable properties.
In October 2022, a collaborative study conducted by researchers from Hofseth BioCare and Stanford University showed that the bioactive peptides in salmon-derived ProGo promote a healthy balance within the gastrointestinal immune system.
Furthermore, it has been observed that the four most common causes of non-communicable disease (NCD) are cardiovascular diseases, cancer, diabetes, and respiratory diseases.
Marine organisms have been found to be a rich source of bioactive peptides that can help in the prevention and treatment of NCD.
Recent pharmacological research has revealed the anti-cancer benefits of marine-derived bioactive peptides in human breast cancer, cervical cancer, liver cancer, and prostate cancer (PC-3).
As a result, several investigations and research are being conducted to better understand the therapeutic roles of bioactive peptides NCD.
| Attributes | Key Insights |
|---|---|
| Estimated Global Bio-active Peptide Market Size (2023E) | USD 2,508.3 million |
| Projected Bio-active Peptide Market Value (2033F) | USD 4,191.8 million |
| Value-based CAGR (2023 to 2033) | 5.3% |
| Top 3 Countries’ Value | USD 3292.6 million |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
| Market Statistics | Details |
|---|---|
| Jan to Jun (H1), 2022 Projected (P) | 4.6% |
| Jul to Dec (H2), 2021 (A) | 4.4% |
| Jul to Dec (H2), 2022 Projected (P) | 5.2% |
| Jan to Jun (H1), 2022 Outlook (O) | 4.2% |
| Jul to Dec (H2), 2022 Outlook (O) | 5.5% |
| BPS Change: H1, 2022 (O) to H1, 2021 (A) | 34 |
| Jan to Jun (H1), 2023 Projected (P) | 4.9% |
| BPS Change: H1, 2022 (O) to H1, 2022 (P) | 39 |
| Jan to Jun (H1), 2021 (A) | 3.9% |
| BPS Change: H2, 2022 (O) to H2, 2022 (P) | -27 |
| BPS Change: H2, 2022 (O) to H2, 2022 (A) | 111 |
At the end of 2022, the global market stood at USD 2,376.8 million. In the subsequent years, the market achieved a significant growth rate of 5.3%, accounting for USD 4,191.8 million in 2033.
The global bioactive peptide market experienced significant growth over the years, driven by extensive research and development efforts undertaken by key industry players.
For instance, NeoMatrix Therapeutics, Inc., recently announced promising results from the Phase 1 clinical trial of their bioactive peptide, NMT-cP12.
This peptide is specifically designed for intravenous treatment of burns, with the potential to be administered within 2 to 4 hours of injury.
Furthermore, an increase in the number of inorganic methods such as product launches which were incorporated by the market competitors resulted in the worldwide growth of the bioactive peptide market.
For example, Rousselot, a collagen-based solutions company, announced the launch of Peptan, an MSC-certified (Marine Stewardship Council) marine collagen peptide made from wild-caught marine white fish and certified by the Marine Stewardship Council (MSC).
It was held at Beauty & Skincare Formulation Conference 2021 to help beauty and nutrition brands differentiate and expand their portfolio in nutria-cosmetics and dietary supplements. Such product launches have impacted positively the growth of the bio-active peptide market.
| Region | North America |
|---|---|
| Country | United States |
| CAGR | 10.2% |
| Market Value (2033) | USD 1,509.0 million |
| Region | Europe |
|---|---|
| Country | Germany |
| CAGR | 4.5% |
| Market Value (2033) | USD 188.6 million |
| Region | Asia Pacific |
|---|---|
| Country | China |
| CAGR | 7.8% |
| Market Value (2033) | USD 1,186.3 million |
| Region | Asia Pacific |
|---|---|
| Country | India |
| CAGR | 9.1% |
| Market Value (2033) | USD 549.1 million |
| Region | Asia Pacific |
|---|---|
| Country | Japan |
| CAGR | 6.9% |
| Market Value (2033) | USD 595.2 million |
Stringent Safety and Regulatory Standards Increased Consumer Trust and Boosted Market
According to FMI analysis, the bio-active peptide market in Germany is expected to grow at a CAGR of 4.5% from 2023 to 2033 to reach a valuation of USD 188.6 million by 2033.
Germany is known for having stringent quality and safety regulations, especially in the food and pharmaceutical industries.
Consumers value the safety and efficacy of bioactive peptide products that meet these stringent standards. This has raised consumer trust and boosted sales of bioactive peptides in Germany.
Besides its regulation, Germany is home to leading pharmaceutical and nutraceutical companies that are constantly differentiating their product offering to stay competitive in the market.
For instance, BASF launched Peptide 4.0, an inflammatory product that is a rice-derived peptide, it is further aiming to launch two more products, PeptiYouth and PeptiStrong, derived from peas and fava beans.
Consistent Research Helping to Discover Various Sources of Bioactive Peptides in the United States
The demand for bioactive peptides in the United States is expected to grow at a CAGR of 10.2% during the forecast period 2023 to 2033, reaching a market size of USD 1,509.0 million by the end of 2033
Ongoing research and development projects in the field of bioactive peptides have resulted in the discovery of peptide sources, improved extraction methods, and enhanced understanding of their bioactivity.
This has led to the development of new ingredients with improved efficacy and safety in the United States.
For instance, Lunacin, a bioactive peptide, is being developed that occurs naturally in soybeans and other plant-based foods.
Over the years, scientists worked on the extraction and purification processes of Lunacin from bioactive sources in a concentrated and standardized form.
This breakthrough helped manufacturers in the United States to incorporate Lunacin in numerous food and dietary supplement products.
Increased adoption of natural, sustainable, and minimally invasive technology driving the market in India.
Bio-active Peptide demand in India is anticipated to grow at a CAGR of 9.1% during the forecast period from 2023 to 2033 to hold a market size of USD 549.1 million by the end of 2033.
Consumers in India are very much attracted to minimally invasive technologies that give preference to sustainability, quality, efficiency, and safety.
As these technologies continue to develop with minimal environmental damage, they will continue to become more widely adopted in India and hence resulting in the production of bioactive peptide-based products.
Besides this, factors such as growing health and wellness awareness, demand for natural and functional ingredients, India's traditional medical legacy, and an emphasis on preventative healthcare play important roles in the increased acceptance of bioactive peptides in the Indian market.
The Hypoallergenic Nature of Plant-Based Bioactive Peptides Drives Demand as An Alternative to Animal-Based Peptides.
Based on the source, demand for plant-based bioactive peptides is expected to continue as it is holding a market share of 34.0% to reach a market valuation of USD 1,425.0 million by the end of 2033.
It is observed that some individuals are allergic to animal-based peptides such as those generated from dairy or shellfish in such cases plant-based peptides cater to the need of these consumers.
Plant-based peptides provide a hypoallergenic alternative and are widely available at retail stores and are more appealing to this segment of the consumer.
Besides this, there are few countries that have stricter restrictions and ethical norms regarding animal-based products which hampers the production and marketing of animal-derived bioactive peptides.
Here as well, plant-derived bioactive peptides act as an alternative solution to fulfill the demand.
Easy Digestibility and Bioavailability of Milk-Derived Bioactive Peptides Peptide Benefiting the Market
According to FMI analysis, the milk bioactive peptides segment is predicted to attain a market share of 35.2% during the assessment period, resulting in a market size of USD 1,467.1 million by 2033.
Industrial-scale processes are already established for extracting biologically active, nondenatured, whey proteins as a direct byproduct of cheese production. Similarly, caseins are produced on a huge scale for culinary products such as cottage cheese.
As a result, salvaging these protein fractions and generating active peptides from them is economically feasible to use as safe and effective natural preservatives, dietary supplements, and milk-based nutraceuticals.
On the other hand, milk proteins, from which milk peptides are derived, are highly digestible and bioavailable due to which the demand for milk bioactive peptides is increasing during the forecast period.
The Presence of Various Health Claims Led to The Establishment of Customer Trust, Which Fuelled the Popularity of Dietary Supplements
According to FMI, the use of Bio-active Peptides in dietary supplements is growing, and it is expected to have a market share of 32.0% and a market size of USD 1,341.3 million by the end of 2033.
Dietary supplements enable the incorporation of health claims and marketing messages emphasizing the specific benefits of bioactive peptides.
This allows manufacturers to target specific health issues or illnesses, such as cardiovascular health, immunological support, or cognitive function.
Furthermore, in comparison to pharmaceuticals and animal feed, the ease of availability, consumer inclination for preventative healthcare, marketing opportunities, and regulatory considerations favor the use of bioactive peptides in dietary supplements.
However, bioactive peptides are still being researched, and their application in various industries, including pharmaceuticals and animal feeding is under process considering their medicinal and performance-enhancing properties.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The Bio-active Peptide market has a diverse and dynamic competitive landscape. To serve industries such as food and drinks, pharmaceuticals, and supplements, leading companies specializing in diverse fields are focusing on research and development, sustainable sourcing, and new formulations.
These companies emphasize environmentally friendly practices, product certifications, and satisfying the increased demand for natural and sustainable ingredients. Additionally, it tries to preserve its market position and capitalize on the growing demand by focusing on quality, innovation, and matching customer preferences.
For instance:
| Attribute | Details |
|---|---|
| Market Size Value in 2023 | USD 2,508.3 million |
| Market Forecast Value in 2033 | USD 4,191.8 million |
| Anticipated Growth Rate (2023 to 2033) | 5.3% CAGR |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | Volume (MT) and Value (USD Million) |
| Key Regions Covered | Latin America; Europe; South Asia; North America; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | United States, Thailand, Mexico, Canada, Indonesia, Chile, Brazil, Peru, Argentina, France, Germany, Spain, Italy, Netherlands, Nordic, Belgium, United Kingdom, Russia, Poland, South Korea, China, Japan, Australia, India, Malaysia, Singapore, New Zealand, GCC Countries, South Africa, Central Africa, and others |
| Key Market Segments Covered | Type, Source, Form, Application, and Region |
| Key Companies Profiled | Angel Yeast Co., Ltd.; BASF SE; Seagarden AS; Archer Daniels Midland Company; Ingredia SA; Rousselot S.A.S.; FrieslandCampina Ingredients; Peptan; Kerry Group plc; CP Kelco USA, Inc.; Others (on additional request) |
The bio-active peptide market is valued at USD 2,508.3 million in 2023.
The market is projected to experience a 5.3% CAGR until 2033.
The market is estimated to be worth USD 4,191.8 million in 2033.
India is anticipated to develop at a CAGR of 9.1% from 2023 to 2033.
Peptan, Kerry Group plc and, CP Kelco USA, Inc. are the key market players.
Explore Functional Food Ingredients Insights
View Reports
Bio-active Peptide Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
